A Growing Health Problem
India is facing a serious rise in [[obesity::a condition of having too much body fat]], not just among adults but also among teenagers and children. Obesity means having too much body fat, and it is not only about looks, but it also increases the risk of diseases like [[diabetes::a disease where the body cannot control blood sugar]], heart problems, and high blood pressure.
Studies show that nearly one in four Indian adults is overweight or obese, and even young people are being affected.
Why It Matters Today
Obesity and diabetes are closely connected in India. Extra body fat makes it harder for the body to control blood sugar, leading to diabetes. India already has over 100 million people with diabetes, and many more are at risk.
Experts say that [[lifestyle::the way a person lives, including habits like eating and exercise]] changes, like eating healthy food and exercising regularly, are still the most important way to stay fit. However, for some people, medicines are also needed when lifestyle changes are not enough.
The New “Super Drugs”
Scientists have developed a new group of medicines called GLP-1 drugs, which help people feel full faster and reduce hunger. These drugs also control blood sugar, making them useful for both obesity and diabetes.
Medicines like Ozempic and Wegovy can lead to [[significant::large or important]] weight loss when combined with healthy habits. But these drugs were very expensive because they were protected by [[patents::legal rights that give one company control over making a product]], meaning only one company could sell them.
What Changed
In March 2026, the patent for these drugs expired in India. This means other companies can now make the same medicine, called [[generic drugs::cheaper versions of medicines made after patents expire]]. As a result, many Indian pharmaceutical companies are launching cheaper versions, and prices are expected to drop by about half.
This could make these powerful medicines more [[affordable::costing less money and easier to buy]] for middle-class patients, though they are still costlier than older drugs. At the same time, the government has warned against misuse and said these medicines must be taken only with a doctor’s advice.
What We Learn
This story shows how science, business, and public health are connected. New medicines can change lives, but high prices limit access. When patents expire, generics make treatment cheaper and available to more people.
Still, medicines are not magic solutions; healthy habits remain the foundation for a healthy body.
Quick Revision
Obesity increases the risk of diseases like diabetes and heart problems.
GLP-1 drugs help control hunger and blood sugar.
Cheaper generic medicines can make treatment available to more people.
